'We need to be prepared': FDA will draft guidance to work with vaccine, drug and testing companies on COVID-19 variants

  • 📰 USATODAY
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 63%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Concerned about new variants of the virus that causes COVID-19, the U.S. Food and Drug Administration says it is developing guidance to help vaccine, drug and testing manufacturers adapt.

, though it likely still offered some protection.

To prevent the evolution of even more dangerous variants, it's crucial to wear a mask, avoid indoor crowds, wash hands frequently and get vaccinated when possible, Fauci said at a White House briefing earlier in the week. All five of the vaccines which the U.S. government has contracted to buy, target the"spike" protein on the surface of the SARS-CoV-2 virus. Mutations to that protein in the South African variant are believed to be behind the reduced vaccine effectiveness.

Some might be able to evade vaccines, treatments and diagnostics, but won't spread enough in the U.S. to pose a problem here.It's not exactly clear how long it would take to make a vaccine that addresses a new variant, or several, because it's never been done before. "This flexibility includes the ability to alter the RNA sequence in the vaccine to cover new strains of the virus," the statement reads."If one ever were to emerge that is not well covered by the current vaccine, the updated vaccine could be administered as a booster."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 100. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Viruses mutate. That is why they have to tweak the flu vaccine every year. That is why there is no vaccine for the common cold. The coronavirus is a cousin to these. The Pfizer CEO may know this, that is why he sold Pfizer stock when their vaccine was announced.

Professional CV Writing I’m Mawande Molosi, an experienced Recruiter, CV Writer and LinkedIn Specialist, expert at revamping CV’s & LinkedIn profiles for Junior, Senior job seekers that deliver real results. Linkedin website - job

Do the best👍🙏

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines